These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 11751995

  • 1. ICA69(null) nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide.
    Winer S, Astsaturov I, Gaedigk R, Hammond-McKibben D, Pilon M, Song A, Kubiak V, Karges W, Arpaia E, McKerlie C, Zucker P, Singh B, Dosch HM.
    J Immunol; 2002 Jan 01; 168(1):475-82. PubMed ID: 11751995
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes.
    Winer S, Gunaratnam L, Astsatourov I, Cheung RK, Kubiak V, Karges W, Hammond-McKibben D, Gaedigk R, Graziano D, Trucco M, Becker DJ, Dosch HM.
    J Immunol; 2000 Oct 01; 165(7):4086-94. PubMed ID: 11034420
    [Abstract] [Full Text] [Related]

  • 4. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes.
    Song A, Winer S, Tsui H, Sampson A, Pasceri P, Ellis J, Elliott JF, Dosch HM.
    Eur J Immunol; 2003 Feb 01; 33(2):546-55. PubMed ID: 12645954
    [Abstract] [Full Text] [Related]

  • 5. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S, Astsaturov I, Cheung R, Tsui H, Song A, Gaedigk R, Winer D, Sampson A, McKerlie C, Bookman A, Dosch HM.
    Lancet; 2002 Oct 05; 360(9339):1063-9. PubMed ID: 12383988
    [Abstract] [Full Text] [Related]

  • 6. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
    Yoon JW, Yoon CS, Lim HW, Huang QQ, Kang Y, Pyun KH, Hirasawa K, Sherwin RS, Jun HS.
    Science; 1999 May 14; 284(5417):1183-7. PubMed ID: 10325232
    [Abstract] [Full Text] [Related]

  • 7. Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.
    Karges W, Hammond-McKibben D, Cheung RK, Visconti M, Shibuya N, Kemp D, Dosch HM.
    Diabetes; 1997 Apr 14; 46(4):557-64. PubMed ID: 9075794
    [Abstract] [Full Text] [Related]

  • 8. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
    Balasa B, La Cava A, Van Gunst K, Mocnik L, Balakrishna D, Nguyen N, Tucker L, Sarvetnick N.
    J Immunol; 2000 Dec 15; 165(12):7330-7. PubMed ID: 11120869
    [Abstract] [Full Text] [Related]

  • 9. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.
    J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
    Balasa B, Van Gunst K, Jung N, Katz JD, Sarvetnick N.
    Cell Immunol; 2000 Jun 15; 202(2):97-102. PubMed ID: 10896769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E, Singh B.
    J Immunol; 2000 Jun 15; 164(12):6610-20. PubMed ID: 10843721
    [Abstract] [Full Text] [Related]

  • 14. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
    Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson DB.
    J Immunol; 2001 Jan 15; 166(2):908-17. PubMed ID: 11145667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O, Militech A, Vaupel BA.
    J Immunol; 2002 Jun 15; 168(12):6159-64. PubMed ID: 12055228
    [Abstract] [Full Text] [Related]

  • 18. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
    Chen W, Bergerot I, Elliott JF, Harrison LC, Abiru N, Eisenbarth GS, Delovitch TL.
    J Immunol; 2001 Nov 01; 167(9):4926-35. PubMed ID: 11673498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.